Comparison of the effectiveness and safety of direct oral anticoagulants: a nationwide propensity score–weighted study

Arnar B. Ingason,Johann P. Hreinsson,Arnar S. Agustsson,Sigrun H. Lund,Edward Rumba,Daniel A. Palsson,Indridi E. Reynisson,Brynja R. Gudmundsdottir,Pall T. Onundarson,Einar S. Bjornsson

Blood Advances（2023）

引用 2|浏览1

暂无评分

摘要

•In this nationwide cohort study, apixaban, dabigatran, and rivaroxaban had similar rates of any stroke or systemic embolism.•Rivaroxaban had higher rates of major bleeding than apixaban and dabigatran but lower rates of myocardial infarction than dabigatran.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要